FDA Adverse Event Other Summary report: N

2.3MM CATHETER OVER-THE-WIRE

MDR report key: 1240904 · Received November 5, 2008

Report

Report Number
1721279-2008-00043
Event Type
Other
Date Received
November 5, 2008
Date of Event
October 21, 2008
Report Date
November 5, 2008
Manufacturer
SPECTRANETICS CORP.
Product Code
GEX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT OUTCOME: THE PT WAS KEPT OVERNIGHT AND DISCHARGED HOME THE FOLLOWING DAY. PRELIMINARY FAILURE ANALYSIS: THERE IS NO INDICATION THAT THE EVENT WAS CAUSED BY A MALFUNCTION OF THE SPNC DEVICE. CORRECTION: BRAND NAME. THE INITIAL FILING DOCUMENTED THE "BRAND NAME" AS BEING A 2.0MM CATHETER OVER-THE-WIRE. THE ACTUAL AND CORRECT BRAND NAME OF THIS DEVICE IS SPNC 2.3MM CATHETER OVER-THE-WIRE.

Description of Event or Problem · 1

CLINICAL HISTORY: PT IS A (B) (6) FEMALE PRESENTING WITH A COMPLETE, TOTAL OCCLUSION OF THE SFA. PROCEDURE: DR (B) (6) TRIED USING A QUICK CROSS DEVICE WITH A WIRE TO CROSS THE LESION WITHOUT SUCCESS. DR (B) (6) IN TO ASSIST DR (B) (6) PASSED A PIONEER CATHETER WITH WIRE SUCCESSFULLY THROUGH THE LESION, DOWN TO THE KNEE. DR (B) (6) THEN REMOVED THE PIONEER CATHETER AND PLACED A 2.3 TE. DR (B) (6) PROCEEDED TO LASE WITH THE 2.3 TE, ASSUMING THE GUIDE WIRE WAS IN THE APPROPRIATE PLACE. FLURO WAS USED THROUGHOUT THE PROCEDURE. A MEMBER OF THE TEAM NOTICED A BLUE LIGHT COMING FROM UNDERNEATH THE STERILE DRAPE. THE MD HAD LASED COMPLETELY THROUGH THE PT'S THIGH, AS THE GUIDEWIRE HAD BEEN RETRACTED FOR AN UNK REASON. THE PT DID NOT COMPLAIN OF ANY PAIN AROUND THE SITE DURING THE PROCEDURE, VITALS WERE STABLE THROUGHOUT, A NURSE HELD DIRECT PRESSURE AT THE SITE OF THE EXIT WOUND AND BLEEDING STOPPED. A POST-PROCEDURE ANGIOGRAM WAS DONE AND SHOWED NO OBVIOUS INJURY TO THE VESSEL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 2.3MM CATHETER OVER-THE-WIRE 2.3 OTW GEX SPECTRANETICS CORP. 423-001 CO8H28B

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention SPECTRANETICS CVX-300 LASER